🇺🇸 FDA
Patent

US 11484602

Bicyclic peptide ligands specific for EphA2

granted A61KA61K38/05A61K38/10

Quick answer

US patent 11484602 (Bicyclic peptide ligands specific for EphA2) held by BicycleTx Limited expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleTx Limited
Grant date
Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/05, A61K38/10, A61K47/62, A61K47/64